Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 7
- −8 vs. Q1 2023
- Portfolio value
- $34.7M
- −$4.94M (−12.5%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SVRASavara Inc | COM | 4,980,804 | $16.0M | 46.2% | −1,915,747−27.8% | Reduced | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 5,641,920 | $14.8M | 42.7% | −397,108−6.6% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $2.61M | 7.5% | −84,190−6.0% | Reduced | History |
| MTEMMolecular Templates, Inc. | COM | 2,052,991 | $985.4K | 2.8% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 43,466 | $138.2K | 0.4% | −168,274−79.5% | Reduced | History |
| ALLKAllakos Inc. | COM | 17,733 | $77.3K | 0.2% | −68,800−79.5% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 21,725 | $33.0K | 0.1% | −46,599−68.2% | Reduced | History |
Sold out since Q1 2023 (8)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 15,947 | $6.53M | 16.5% | History |
| SPDR Series Trust78468R556 | SP O&G EXPL PRO | 17,500 | $2.23M | 5.6% | – |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 156,651 | $1.35M | 3.4% | – |
| Alps ETF Tr00162Q452 | ALERIAN MLP | 29,500 | $1.14M | 2.9% | – |
| CABACabaletta Bio, Inc. | COM | 40,581 | $335.6K | 0.8% | History |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 21,333 | $40.5K | 0.1% | History |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 39,773 | $6.97K | <0.1% | – |
| LANWFLanvin Group Holdings Ltd | *W EXP 99/99/999 | 12,000 | $4.50K | <0.1% | History |